Dolby Laboratories Inc. (DLB)

Here is how Dolby Laboratories (DLB) and Netflix (NFLX) have performed compared to their sector so far this year.

Dolby Laboratories (DLB) reported earnings 30 days ago. What's next for the stock?

Strength in Dolby Atmos and Dolby Vision, synergies from acquisitions and focus on shareholder returns make DLB an attractive investment opportunity.

This monthly article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitati...

Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 ...

Dolby Laboratories (DLB) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

The headline numbers for Dolby Laboratories (DLB) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall St...

DLB's fiscal first-quarter 2025 performance gains from steady growth in the Licensing, and the Products and services segments.

Dolby Laboratories, Inc. (NYSE:DLB ) Q1 2025 Earnings Conference Call January 29, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - President, CEO & Director Robert Park - ...

Dolby Laboratories (DLB) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.01 per share a year ago.